Compounds > aripiprazole
Page last updated: 2024-08-24

aripiprazole and Hyperactivity, Motor

aripiprazole has been researched along with Hyperactivity, Motor in 12 studies

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (25.00)29.6817
2010's9 (75.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bai, X; Chen, M; Chen, X; Frye, SV; Jin, J; Roth, BL; Sassano, MF; Setola, V; Wetsel, WC; Zheng, L1
Bojarski, AJ; Bucki, A; Byrtus, H; Czopek, A; Kalinowska-Tłuścik, J; Kazek, G; Kołaczkowski, M; Partyka, A; Pawłowski, M; Piaskowska, A; Wesołowska, A1
Lorenc-Koci, E; Rogóż, Z; Wąsik, A1
Gao, J; Li, M; Qin, R1
Connolly, JG; Schneeweiss, MC; Toomey, TJ1
Hirsch, LE; Pringsheim, T1
Baldaia, MA; Berro, LF; Frussa-Filho, R; Hollais, AW; Marinho, E; Oliveira-Lima, AJ; Ribeiro, LT; Santos-Baldaia, R; Talhati, F; Wuo-Silva, R1
Amano, T; Asato, M; Hashimoto, K; Ikegami, D; Kuzumaki, N; Matsushima, Y; Nakamura, A; Narita, M; Niikura, K; Shiokawa, M; Suzuki, T; Takagi, S; Takei, D; Tsurukawa, Y1
Bernardi, G; Brusa, L; Iani, C; Mercuri, NB; Moschella, V; Orlacchio, A1
Avenet, P; Bergis, O; Boulay, D; Griebel, G1
Ching, H; Pringsheim, T1
Guimarães, FS; Leite, JV; Moreira, FA1

Reviews

2 review(s) available for aripiprazole and Hyperactivity, Motor

ArticleYear
Aripiprazole for autism spectrum disorders (ASD).
    The Cochrane database of systematic reviews, 2016, Jun-26, Issue:6

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Child Development Disorders, Pervasive; Female; Humans; Hyperkinesis; Irritable Mood; Male; Randomized Controlled Trials as Topic

2016
Aripiprazole for autism spectrum disorders (ASD).
    The Cochrane database of systematic reviews, 2012, May-16, Issue:5

    Topics: Adolescent; Antipsychotic Agents; Aripiprazole; Child; Child Development Disorders, Pervasive; Female; Humans; Hyperkinesis; Irritable Mood; Male; Piperazines; Quinolones; Randomized Controlled Trials as Topic

2012

Trials

1 trial(s) available for aripiprazole and Hyperactivity, Motor

ArticleYear
Treatment of the symptoms of Huntington's disease: preliminary results comparing aripiprazole and tetrabenazine.
    Movement disorders : official journal of the Movement Disorder Society, 2009, Jan-15, Volume: 24, Issue:1

    Topics: Adult; Aged; Aripiprazole; Cross-Over Studies; Dopamine Agents; Dyskinesia, Drug-Induced; Female; Humans; Huntingtin Protein; Huntington Disease; Hyperkinesis; Male; Middle Aged; Nerve Tissue Proteins; Nuclear Proteins; Piperazines; Quinolones; Receptors, Dopamine D2; Tetrabenazine; Trinucleotide Repeats

2009

Other Studies

9 other study(ies) available for aripiprazole and Hyperactivity, Motor

ArticleYear
Structure-functional selectivity relationship studies of β-arrestin-biased dopamine D₂ receptor agonists.
    Journal of medicinal chemistry, 2012, Aug-23, Volume: 55, Issue:16

    Topics: Animals; Antipsychotic Agents; Aripiprazole; Arrestins; beta-Arrestins; CHO Cells; Cricetinae; Cricetulus; Cyclic AMP; Female; HEK293 Cells; Humans; Hyperkinesis; Ligands; Male; Mice; Mice, Knockout; Phencyclidine; Piperazines; Quinolones; Radioligand Assay; Receptors, Dopamine D2; Structure-Activity Relationship

2012
Novel spirohydantoin derivative as a potent multireceptor-active antipsychotic and antidepressant agent.
    Bioorganic & medicinal chemistry, 2015, Jul-01, Volume: 23, Issue:13

    Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Anxiety; Aripiprazole; Depression; Dextroamphetamine; Hydantoins; Hyperkinesis; Imidazolidines; Male; Mice; Piperazines; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Receptors, Serotonin; Structure-Activity Relationship; Swimming

2015
Combined treatment with aripiprazole and antidepressants reversed some MK-801-induced schizophrenia-like symptoms in mice.
    Pharmacological reports : PR, 2018, Volume: 70, Issue:4

    Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Aripiprazole; Citalopram; Disease Models, Animal; Dizocilpine Maleate; Drug Synergism; Drug Therapy, Combination; Hyperkinesis; Male; Memory Disorders; Mianserin; Mice; Mirtazapine; Recognition, Psychology; Schizophrenia; Schizophrenic Psychology

2018
Repeated administration of aripiprazole produces a sensitization effect in the suppression of avoidance responding and phencyclidine-induced hyperlocomotion and increases D2 receptor-mediated behavioral function.
    Journal of psychopharmacology (Oxford, England), 2015, Volume: 29, Issue:4

    Topics: Animals; Antipsychotic Agents; Aripiprazole; Avoidance Learning; Behavior, Animal; Brain; Dose-Response Relationship, Drug; Hyperkinesis; Male; Phencyclidine; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2

2015
Metabolic monitoring for youths initiating use of second-generation antipsychotics, 2003-2011.
    Psychiatric services (Washington, D.C.), 2015, Volume: 66, Issue:6

    Topics: Adolescent; Affective Disorders, Psychotic; Antipsychotic Agents; Anxiety Disorders; Aripiprazole; Benzodiazepines; Blood Glucose; Child; Child, Preschool; Cohort Studies; Conduct Disorder; Databases, Factual; Depressive Disorder; Diabetes Mellitus; Female; Glycated Hemoglobin; Guideline Adherence; Humans; Hyperkinesis; Male; Mass Screening; Mental Disorders; Olanzapine; Piperazines; Practice Guidelines as Topic; Practice Patterns, Physicians'; Psychotic Disorders; Quetiapine Fumarate; Retrospective Studies; Risperidone; Thiazoles

2015
Context-dependent efficacy of a counter-conditioning strategy with atypical neuroleptic drugs in mice previously sensitized to cocaine.
    Progress in neuro-psychopharmacology & biological psychiatry, 2017, 02-06, Volume: 73

    Topics: Animals; Antipsychotic Agents; Aripiprazole; Cocaine; Conditioning, Operant; Dopamine Uptake Inhibitors; Exploratory Behavior; Hyperkinesis; Locomotion; Male; Mice; Piperazines; Statistics, Nonparametric; Thiazoles

2017
Suppression of dopamine-related side effects of morphine by aripiprazole, a dopamine system stabilizer.
    European journal of pharmacology, 2008, Dec-14, Volume: 600, Issue:1-3

    Topics: Analgesics, Opioid; Animals; Antipsychotic Agents; Aripiprazole; Catalepsy; Dopamine; Dopamine Antagonists; Dose-Response Relationship, Drug; Hyperkinesis; Male; Mice; Mice, Inbred ICR; Morphine; Nucleus Accumbens; Piperazines; Prochlorperazine; Quinolones; Reward; Severity of Illness Index

2008
The glycine transporter-1 inhibitor SSR103800 displays a selective and specific antipsychotic-like profile in normal and transgenic mice.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2010, Volume: 35, Issue:2

    Topics: Amphetamine; Analysis of Variance; Animals; Antipsychotic Agents; Aripiprazole; Catalepsy; Clozapine; Disease Models, Animal; Dizocilpine Maleate; Dopamine Plasma Membrane Transport Proteins; Glycine Plasma Membrane Transport Proteins; Hyperkinesis; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Piperazines; Quinolones; Receptors, N-Methyl-D-Aspartate

2010
Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice.
    European journal of pharmacology, 2008, Jan-14, Volume: 578, Issue:2-3

    Topics: Amphetamine; Animals; Antipsychotic Agents; Aripiprazole; Catalepsy; Central Nervous System Stimulants; Cocaine; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Partial Agonism; Excitatory Amino Acid Antagonists; Glutamine; Haloperidol; Hyperkinesis; Ketamine; Locomotion; Male; Mice; Motor Activity; Piperazines; Quinolones; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Time Factors

2008